|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Immunogenicity and safetyof different injection routes and schedules of IC41,a hepatitis Cvirus (HCV) peptide vaccine 显示文摘 | Firbas C Boehm T Buerger V | 2010 | Vaccine2010，28，12： | 1 |
| 2 | Immunogenicity, safety, and tolerability of a recombinant mcaslcs-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first- in-man trial 显示文摘 | Ramsauer K Schwameis M Firbas C Milliner M Putnak ILl Thomas SJ Despr6s P Tauber E Jilma B Tangy F | 2015 | Lancet Infect Dis2015，15，5： | 1 |
| 3 | Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine显示文摘 | Firbas C Boehm T Buerger V et ai | 2010 | Vaccine2010，28，12： | 1 |
| 4 | Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia显示文摘 | Leitner J M Firbas C Mayr F B | | 0，，： | 1 |
| 5 | Validation of rotation throm-belastography in a model of systemic activation of fibrinolysis and coag-ulation in humans显示文摘 | SpielA 0 Mayr F B Firbas C | 2006 | J Thromb Haemost2006，4，2： | 1 |
| 6 | lmmunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) pep- tide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects 显示文摘 | Firbas C Jilma B Tauber E Buerger V Jelovcan S Ling- nau K Buschle M Frisch J Klade CS | 2006 | Vaccine2006，24，20： | 1 |
| 7 | Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C 显示文摘 | Wedemeyer H Schuller E Schlaphoff V Stauber RE Wiegand J Schiefke I Firbas C Jilma B Thursz M Zeuzem S Hofmann WP Hinrichsen H Tauber E Manns MP Klade CS | 2009 | Vaccine2009，27，37： | 1 |
| 8 | Validation of rotation thrombo- elastography in a model of systemic activation of fibrinolysis and coagulation in humans显示文摘 | Spiel AO Mayr FB Firbas C | 2006 | Thromb Haemost2006，4，： | 1 |
| 9 | Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine:a randomized,placebo controlled trial for dose op-timization in 128 healthy subjects显示文摘 | Firbas C Jilma B Tauber E | 2006 | Vaccine2006，24，20： | 1 |
| 10 | Validation of rotation thrombelas-tography in a model of systemic activation of fibrinolysis and coagulation in humans 显示文摘 | Spiel AO Mayr FB Firbas C | 2006 | J Thromb Haemost2006，4，2： | 1 |
| 11 | Targeting von wille-brand factor and platelet glycoprotein Ib receptor显示文摘 | Firbas C Siller-Matula JM Jilma B | 2010 | ExpertRev Cardiovasc Ther2010，8，： | 1 |
| 12 | Validation of rotation thromboelastography in a model of systemic activation of fibrinolysis and coagulation in humans显示文摘 | Spiel AO Mayr FB Firbas C | 2006 | Thromb Haemost2006，4，2： | 1 |
| 13 | Targeting yon Winebrand fac- tor and platelet glycoprotein Ib receptor显示文摘 | Firbas C Siller-Matula JM Jilma B | 2010 | Expert Rev Cardiovasc Ther2010，8，12： | 1 |
| 14 | Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects 显示文摘 | Firbas C Jilma B Tauber E | 2006 | Vaccine2006，24，20： | 1 |
| 15 | Immunogenicity andsafety of a novel therapeutic hepatitis C virus (HCV) peptidevaccine: a randomized,placebo controlled trial for dose opti-mization in 128 healthy subjects显示文摘 | Firbas C Bernd J Tauber E | 2006 | Vaccine2006，24，： | 1 |
| 16 | Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans 显示文摘 | Spiel AO Mayr FB Firbas C | 2006 | Journal of thrombosis and haemo- stasis : JTH2006，4，2： | 1 |
| 17 | Validation of rotation throm-belastography in a model of systemic activation of fibrinolysis and co-agulation in humans显示文摘 | Spiel A O Mayr F B Firbas C | 2006 | J Thromb Haemost2006，4，2： | 1 |
| 18 | Targeting von Willebrand factor and platelet glycoprotein Ib receptor显示文摘 | Firbas C Siller-Matula JM Jilma B | 2010 | Expert Rev Cardiovasc Ther2010，8，12： | 1 |
| 19 | Targeting von Willebrand factor and platelet glycoprotein Ib receptor显示文摘 | Firbas C Siller-Matula JM Jilma B | | 0，，12： | 1 |
| 20 | Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans 显示文摘 | Spiel A O Mayr F B Firbas C | 2006 | J Thromb Haemost2006，4，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员